1. Research on the Development Path of Building a World-class Pharmacy Discipline
Chinese Pharmaceutical Journal 2020;55(14):1220-1226
OBJECTIVE: To analyze the current status of China's pharmacy discipline rankings, and compare the development gap between China's pharmacy disciplines and world-class pharmacy disciplines to explores the development path of building a world-class pharmacy discipline. METHODSE: Website research, literature research, and comparative analysis were adopted. RESULTS AND CONCLUSION: The ranking status of pharmacy disciplines in China is compared and analyzed, and from the three aspects of the index system, international influence, and innovative talents training, the development path of building world-class pharmacy discipline in China is proposed.
2. Peroxisome proliferator-activated receptor γ and regulation of adaptive thermogenesis
Journal of International Pharmaceutical Research 2015;42(1):1-7
Adaptive thermogenesis is an important manner to keep homeostasis of energy metabolism by non-shivering thermogenesis(NS). In addition to brown adipose tissue, the beige adipose tissue induced by cold stimulation in subcutaneous white adipose tissue (WAT) also proceeds NS in mice. Regulating NS to increase excess energy expense of the body may be a safe and effective method for the treatment of obesity, insulin resistance and the disorder of energy metabolism. Peroxisome proliferator-activated receptor γ(PPARγ) is an important transcription factor whose activator can induce the production of adipose tissue cell in pharmacological doses. This paper reviewes the function of PPARγ in adaptive thermogenesis and analyzes the possible mechanism of selective modulation of PPARγ. It may become the theoretical basis of a new generation of insulin sensitizing agent.
3. A urinary metabonomic research on the intervention effects of Gushudan on prednisolone-induced oesteoprosis rats by RP-UPLC-MS and HILIC-UPLC-MS
Chinese Pharmaceutical Journal 2016;51(23):2045-2052
OBJECTIVE: To develop an intergrated urinary metabonomic strategy based on RP-UPLC-MS and HILIC-UPLC-MS method and to investigated the mechanism of osteoporosis and the prevention effect of glucocorticoid osteoporosis of Gushudan. METHODS: The RP-UPLC-MS and HILIC-UPLC-MS method were developed for rat urine metabolite profiling study among control group, model group and Gushudan treatment group. Principal component analysis (PCA) were used to find the biomarkers, further more, to explore the mechanism of the prevention effect on glucocorticoid osteoporosis of Gushudan. RESULTS: In the mode of RP-UPLC-MS, low polarity metabolites like phenylacetylglycine, N2-succinic acid-L-ornithine were found while relatively high polarity metabolites like betaine, hypoxanthine were found in the mode of HILIC-UPLC-MS. And twenty-two potential biomarkers have been totaly found in the urine of glucocorticoid osteoporosis, primiarily related to amino acid metabolism, energy metabolism, lipid metabolism, intestinal flora metabolism and kidney damage. Gushudan has intervention effects on rats with osteoprosis via the regulation of multiplemetabolic pathways. CONCLUSION: The combination of RP-UPLC-MS and HILIC-UPLC-MS method can give a more comprehensive profiling of endogenous metabolites and it also indicates metabonomic strategy has become a powerful tool to evaluate the overall efficacy of traditional Chinese medicine (TCM) and to calrify the mechanism of TCM.
4.Techniques and methods evaluation on pharmaceutical stability of liposomes
Zi-yuan HUANG ; Yu-qi SUN ; Hai-yang HU ; Rui ZHUANG ; Qi XU ; Da-wei CHEN
Acta Pharmaceutica Sinica 2016;51(3):356-
Liposomes as a drug carrier is easy to form aggregation and cause drug leakage in vitro. In addition, the degradation and elimination in vivo happens frequently to reduce its delivery activity. Development and application of liposomes are restricted by the instability. The appropriate techniques and methods are great important in the study of pharmaceutical stability of liposomes. In this paper, the techniques and methods are reviewed on pharmaceutical stability evaluation of liposomes, which was done from physical, chemical and biological stability for the difference in stability of liposomes. The research strategies for establishing the stability evaluation system and improving the value of liposomes have been discussed to make full therapeutic advantage of it.
5.Studies on chemical constituents from stellaria media. I.
Qi DONG ; Yuan HUANG ; Shan-yi QIAO
China Journal of Chinese Materia Medica 2007;32(11):1048-1051
OBJECTIVETo study the chemical constituents of Stellaria media.
METHODThe compounds were isolated with various column chromatography and semi-preparative HPLC. The structures were determined by modem spectroscopic methods (IR, UV, 1H-NMR, 13C-NMR, HMBC, ESI-MS).
RESULTFive compounds were isolated and identified as apigenin 6-C-beta-D-galactopyranosyl-8-C-alpha-L-arabinopyranoside (1), apigenin 6-C-alpha-L-arabinopyranosyl-8-C-beta-D-galactopyranoside (2), apigenin 6-C-beta-D-galactopyranosyl-8-C-beta-L-arabinopyranoside (3), apigenin 6-C-beta-D-glucopyranosyl-8-C-beta-D-galactopyranoside (4), apigenin 6, 8-di-C-alpha-L-arabinopyranoside (5).
CONCLUSIONCompounds 1-5 were obtained from Stellaria genus for the first time.
Apigenin ; chemistry ; isolation & purification ; Chromatography, High Pressure Liquid ; methods ; Flavones ; chemistry ; isolation & purification ; Galactosides ; chemistry ; isolation & purification ; Plants, Medicinal ; chemistry ; Stellaria ; chemistry
6.Analysis of Retail Pharmacy Layout in Liaoning Province Based on the Government Perspective
China Pharmacy 2020;31(3):270-275
OBJECTIVE:To investigate rationality of existing retail pharmacy layout in Liaoning province ,and to discuss the rationalization of retail pharmacy layout from the perspective of the government. METHODS :By introducing the concept of coverage radius ,comprehensive use of population ,area,number of retail pharmacies ,average number of people covered by each retail pharmacy ,the difference between the number of pharmacies (calculated according to the coverage radius and area )and the number of existing pharmacies ,the shortest distance between two retail pharmacies as indicators ,the overall retail pharmacies layout in 14 cities of Liaoning province and the specific layout of retail pharmacies in Shenyang were analyzed to put forward the idea of optimizing the retail pharmacies layout. RESULTS & CONCLUSIONS :The correlation of the number of existing retail pharmacies in Liaoning province with the population and land area to a certain extent showed no obvious law ,with some degree randomness. The average number of people covered by each pharmacy is 1 917-4 157 in each city ;the average number of people covered by retail pharmacies in the remaining 10 cities like Yingkou is lower than the provincial average. The average number of people covered in Chaoyang and other 3 cities is higher ,with great development space. The number of existing retail pharmacies in 8 districts and counties such as Tiexi district do not meet the actual needs of consumers (the number of existing pharmacies is 2- 3 921 less than the number of due pharmacies ),while the number of existing retail pharmacies in 3 districts such as Shenhe district far exceeds the required number (the number of existing pharmacies is 142-248 more than the number of due pharmacies ). There is a problem of too small spacing between adjacent retail pharmacies (the minimum distance is less than 500 m). The distribution of retail pharmacies in Liaoning province is unbalanced ,and there is insufficient demand in some areas. When optimizing of retail pharmacies layout ,the government should establish a double objective evaluation system ,which is fair (measured by the maximum distance between the uncovered demand area and the nearest retail pharmacies )and efficient (measured by the sum of the number of retail drugstores needed for the existing layout and the number of new retail drugstores ). It is also necessary to analyze and construct a retail pharmacies location model which is suitable for China ’s national conditions ,and consider the actual conditions of the parameters of the actual constraints and objective constraints ,so as to realize the overall optimization of retail drugstores .
7.Research on Dual-channel Pricing Strategy of Pharmaceutical Retailing Considering Medical Insurance Payment Policy
China Pharmacy 2021;32(16):1926-1932
OBJECTIVE:To provide reference for the drug retailers when making dual-channel pricing decisions in China. METHODS:Based on the analysis of the existing literature and the characteristics of drug supply chain ,taking the dual-channel drug retailers as the research object ,the effects of medical insurance payment policy ,consumers’risk aversion factor and inconvenience cost on consumers ’decision-making behavior were considered ,and dual-channel pricing strategy model for drug retailers was constructed. The reverse induction method was adopted to analyze and solve the model ,obtain the optimal pricing and optimal profit function of the drug retailer. The numerical simulation was adopted to simulate and analyze the effects of consumer medical insurance payment utility ,risk aversion factor and inconvenience cost on drug retailer dual-channel pricing and profits. RESULTS:When the utility of medical insurance payment increased ,the pricing of drugstores and the total profit of dual-channel of drug retailers would increase ;while consumers ’risk aversion factor and inconvenience cost showed a U-shaped trend with retailer ’s dual-channel total profits. In addition ,compared with existing e-commerce platforms ,retailers could make more profits by building their own e-commerce platforms. CONCLUSIONS :Medical insurance payment policy has a great impact on the profits of dual-channel drug retailers. Drug retailers should continue to pay attention to the trend of relevant national policies and ensure their own profits by adjusting pricing in time. When medical insurance payment utility is in low level ,dual-channel drug retailers can ensure market demand by reducing the retail price of drugstores ,and should use flexible sales strategies to attract consumers. For consumers’risk aversion and inconvenience cost ,drug retailers can adopt strategies such as providing distribution services for consumers with high inconvenience cost.
8.Study on cost-utility threshold based on the preference of population in Liaoning province
Lihua SUN ; Shiqi LI ; Ziping YE ; Abduhilil RAELA ; Jiaxin HUANG
China Pharmacy 2023;34(12):1473-1477
OBJECTIVE To study the cost-utility threshold (WTP/Q) based on the preference of the population in Liaoning province with willingness-to-pay(WTP) survey method, and to provide reference for decision-making. METHODS Using the method of questionnaire survey, quota sampling combined with snowball sampling were used to conduct telephone interviews with the general population in Liaoning province, collect data and analyze it. Probit regression combined with generalized linear model was used to analyze the relevant factors affecting WTP/Q. RESULTS A total of 755 general people were recruited. The WTP/Q of Liaoning population was 119 175 yuan,the average WTP/Q for improving the quality of life was 84 902 yuan, and the average WTP/Q for extending the survival period was 188 005 yuan. The analysis of influential factors showed that the older the age, the lower the probability of people purchasing medical interventions; the higher the education level and income, the greater the WTP/ Q; at the same time, the physical feelings of the interviewee, such as pain and depression, could also affect the WTP/Q results; compared with the scenario of improving quality of life, the WTP/Q for the extended survival period was higher. CONCLUSIONS The WTP/Q of Liaoning province based on the WTP survey method is about 2.07 times of the per capita gross domestic product of Liaoning province in the same period. The WTP/Q for extending survival period is about 2.21 times that of improving the quality of life. Therefore, interventions to improve quality of life and to extend the survival period need to be treated differently, in measurement or decision-making.
9.Study on Green Innovation in Pharmaceutical Enterprises Based on Grounded Theory
Shijia WANG ; Zhe HUANG ; Yongxi ZHAO
China Pharmacy 2020;31(23):2822-2827
OBJECTIVE:To study the influential factors for green innovation in pharmaceutical enterprises based on grounded theory so as to provide reference for pharmaceutical enterprises to enhance their green innovation ability and the government to issue relevant green policies. METHODS :The grounded theory research methods were used to select enterprise samples and follow-up research. Firstly ,56 staffs from 22 sample enterprises (all were pharmaceutical companies )were interviewed in depth one-on-one and face-to-face on issues related to the influential factors for green innovation. Then ,open coding ,spindle coding and selective coding were carried out on the conversation record data ,and conduct theoretical saturation testing was conducted. Finally , the influential factor model of green innovation in pharmaceutical enterprises was constructed ,and its main influential factors were analyzed. RESULTS & CONCLUSIONS :The government demand ,social demand ,industry demand ,green innovation ability , environmental awareness of leaders and overall vision of leaders have significant influence on the green innovation of pharmaceutical enterprises. Among them ,leadership decision (including leaders ’environmental awareness and leadership pattern ) is the internal decisive factor ,green innovation ability (including green innovation investment capacity ,green innovation research and development capacity ,green innovation transformation capacity and green innovation production capacity )is the internal driving factor ,social system (including government needs ,social needs and industry needs )is the external factor ;they are the main factors affecting the green innovation of pharmaceutical enterprises ,and they all have a positive effect on the green innovation of pharmaceutical companies.
10.Establishment of Rational Drug Use Evaluation Model Based on 360-degree Feedback Evaluation Method and Hesitant Fuzzy Sets Theory
Wenjie WANG ; Yuying LIU ; Zhe HUANG
China Pharmacy 2019;30(2):154-159
OBJECTIVE: To establish a comprehensive and multi-angle evaluation model for rational drug use in medical institutions, and to provide support for rational drug use in medical institutions. METHODS: Referring to the phenomenon of irrational drug use and its influential factors in medical institutions, rational drug use evaluation indicator system, which contained 3 evaluation subjects, 6 first-level indicators and 15 second-level indicators, was established on the basis of 360-degree Feedback Method, with hospitals at the same level, superior regulation department and patient as subjects of multi-angle evaluation. At the same time, the linguistic information of vague and uncertain evaluation given by the evaluation subject was comprehensively quantified by Hesitant Fuzzy Sets Theory. The total evaluation score of rational drug use in the evaluated medical institutions was calculated by using the score function formula of hesitant fuzzy number; the level of rational drug use in medical institutions was determined according to the score (the higher the total score, the higher the comprehensive level of rational drug use). RESULTS: An all-round and multi-angle evaluation model of rational drug use in medical institutions was established. According to the evaluation index system based on 360-degree feedback evaluation method, the evaluation subject and weight of evaluation index were determined, the grade of evaluation index was divided, the hesitant fuzzy numbers of each index were gathered, and the first-level index was weighted. Finally, the total evaluation score of rational drug use in medical institutions was calculated; the examples were set to prove the feasibility of the model. CONCLUSIONS: The established evaluation model for rational drug use in medical institutions based on 360-degree Feedback Method and Hesitant Fuzzy Sets Theory can comprehensively and effectively evaluate the rational drug use in medical institutions, and contribute to standardizing and improving clinical drug use behavior in medical institutions.